Immunotherapy Combination Tolerable & Effective in Advanced Kidney Cancer Patients – Technology Networks
Technology Networks |
Immunotherapy Combination Tolerable & Effective in Advanced Kidney Cancer Patients
Technology Networks Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney … |
